Research map: Not all antipsychotic polypharmacy is the same

Back to the article

Papers in this map

  1. The American Psychiatric Association Practice Guideline for the Treatment of Patients With Schizophrenia · George A. Keepers · 2020 · 920 citations · Cited by this paper
  2. Lumateperone monotherapy for major depressive episodes associated with bipolar disorder: efficacy and safety in a randomized placebo-controlled trial · 2025 · Related
  3. Management of common adverse effects of antipsychotic medications · T. Scott Stroup · 2018 · 578 citations · Cited by this paper
  4. Unspoken needs: an essential perspective in the treatment of schizophrenia · 2026 · Related
  5. World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, Part 2: Update 2012 on the long-term treatment of schizophrenia and management of antipsychotic-induced side effects · Alkomiet Hasan · 2012 · 421 citations · Cited by this paper
  6. When antidepressants meet the gut microbiota: implications and challenges · 2024 · Related
  7. Prevalence and correlates of antipsychotic polypharmacy: A systematic review and meta-regression of global and regional trends from the 1970s to 2009 · Juan A. Gallego · 2012 · 331 citations · Cited by this paper
  8. Innovations and challenges in antipsychotic treatments and external modulating factors · 2025 · Related
  9. Association of Antipsychotic Polypharmacy vs Monotherapy With Psychiatric Rehospitalization Among Adults With Schizophrenia · Jari Tiihonen · 2019 · 299 citations · Cited by this paper
  10. Brexpiprazole augmentation in treatment-resistant obsessive-compulsive disorder: a preliminary retrospective observational study · 2025 · Related
  11. Gender Differences in the Prescribing of Antipsychotic Drugs · Mary V. Seeman · 2004 · 221 citations · Cited by this paper
  12. The effects of lurasidone on five symptom domains and individual items in schizophrenia: Post-hoc analysis from Phase 3 study · 2025 · Related
  13. Antipsychotic Polypharmacy for the Management of Schizophrenia: Evidence and Recommendations · Markku Lähteenvuo · 2021 · 154 citations · Cited by this paper
  14. Risperidone as an adjuvant treatment for obsessive-compulsive symptoms in patients with bipolar disorder: a randomized, double-blind, placebo-controlled clinical trial · 2025 · Related
  15. Antipsychotic Polypharmacy · Christoph Ulrich Correll · 2012 · 123 citations · Cited by this paper
  16. Association between anxious depression and clinical outcomes in subjects with treatment-resistant depression: a comparative effectiveness research trial for antidepressant incomplete and non-responders with treatment-resistant depression (ASCERTAIN-TRD) · 2026 · Related
  17. Sex differences in antipsychotic efficacy and side effects in schizophrenia spectrum disorder: results from the BeSt InTro study · Sanne Hoekstra · 2021 · 76 citations · Cited by this paper
  18. Addressing the challenge of treatment adherence in major depressive disorder in different settings · 2026 · Related
  19. Sex differences in schizophrenia relevant to clinical care · Mary V. Seeman · 2021 · 60 citations · Cited by this paper
  20. Interventions to reduce antipsychotic polypharmacy: A systematic review · Hideaki Tani · 2012 · 58 citations · Cited by this paper
  21. Prevalence, correlates, tolerability-related outcomes, and efficacy-related outcomes of antipsychotic polypharmacy: a systematic review and meta-analysis · Mikkel Højlund · 2024 · 58 citations · Cited by this paper
  22. Safety of Antipsychotic Polypharmacy Versus Monotherapy in a Nationwide Cohort of 61,889 Patients With Schizophrenia · Heidi T. Taipale · 2023 · 46 citations · Cited by this paper
  23. Antipsychotic polypharmacy: A Japanese survey of prescribers' attitudes and rationales · Taishiro Kishimoto · 2013 · 38 citations · Cited by this paper
  24. Evidence-Based Recommendations for the Pharmacological Treatment of Women with Schizophrenia Spectrum Disorders · Bodyl A. Brand · 2023 · 26 citations · Cited by this paper
  25. Analysis of the trends of polypharmacy and high‐dose prescriptions in Japan · Naotaka Shinfuku · 2021 · 14 citations · Cited by this paper
  26. Deprescribing antipsychotics in patients with schizophrenia: findings from a specialized clinic · Alexander Nøstdal · 2024 · 11 citations · Cited by this paper
  27. Antipsychotic polypharmacy in Japanese outpatients with schizophrenia: prevalence and sex- and age-related patterns · Rintaro Sogawa · 2026 · 1 citation · Cited by this paper

Source: OpenAlex (CC0)